2014: ASH First clinical results of P2 study of SGI-110 in intermediate or high risk MDS or CMML 25 November 2014/in 2014, Guadecitabine (SGI-110) – (Hematologic Malignancies), Products /by webadmin2014: ASH First clinical results of P2 study of SGI-110 in intermediate or high risk MDS or CMML /wp-content/uploads/2016/11/logo.png 0 0 webadmin /wp-content/uploads/2016/11/logo.png webadmin2014-11-25 16:22:432016-11-25 16:23:132014: ASH First clinical results of P2 study of SGI-110 in intermediate or high risk MDS or CMML
